On Janaushadhi Diwas this year (i.e., March 7th, 2022), Prime Minister Shri Narendra Modi stated that the poor and the middle-class benefited from the 'Jan Aushadhi Kendras' that were set up to provide generic drugs at affordable prices. He said that the poor and the middle class saved around Rs.13,000 crore through these stores during the COVID-19 pandemic. In the wake of COVID 19 crisis, the 'Bureau of Pharma PSUs of India'...

-The Hindu With reforms promoting innovation and lowering the cost of doing business, India is poised to attract the best investments Vietnam and Bangladesh are on a roll. While Bangladesh has become the second largest apparel exporter after China, Vietnam’s exports have grown by about 240% in the past eight years. What has helped them? And what can India learn from them? Two nations and their success stories An open trade policy, a less...

-Livemint.com The production of ‘mahua’ is finally entering the formal economy as new initiatives seek to upscale this indigenous drink, selling it across the country and even the globe It is a cloudy morning in Nangur village in Bastar district, Chattisgarh. It is a settlement of a little over 400 families, considered fairly large in these parts. We make a bumpy journey down a narrow, unpaved road intermittently shaded by sargi (sal)...

-The Telegraph New Delhi: The Narendra Modi government has met a key demand of single-brand retailers by relaxing a mandatory 30 per cent local sourcing condition. The change was announced along with the decision to allow 100 per cent foreign direct investment under the automatic route for single-brand retail trading, which will help companies like Apple to set up branded stores across India. Foreign retailers will now be permitted to set off their...

-The Telegraph New Delhi: India's drug pricing rules allow companies to inflate the maximum retail prices of medicines, including life-saving drugs, costing patients thousands of additional rupees while offering slices of the profits to stockists, chemists, and hospitals. Quotations received by hospitals from drug companies' representatives offering discounts on maximum retail prices (MRPs) of medicines provide what some doctors and patients' rights advocates say is fresh evidence for excessive profiteering in India's...